Paresma Patel, PhD U.S. FDA

Paresma Patel, Ph.D. is a Branch Chief in the Office of New Drug Products, Division of New Drug API. She started at the FDA in 2015 as a review chemist supporting the oncology divisions. She has worked across multiple clinical divisions as a drug substance and drug product chemistry, manufacturing and controls (CMC) reviewer and served as a Quality Lead for two years prior to her current role. Prior to FDA, she worked as a medicinal chemist at the National Institutes of Health with a focus on target validation and lead optimization of small molecule kinase inhibitors. Dr. Patel completed her Ph.D. in organic chemistry at The Scripps Research Institute in 2010 working on the development and application of novel chemistry methods. Following her graduate work, she completed a postdoctoral fellowship at the California Institute of Technology working on the development of novel ruthenium-based catalysts and synthesis of bioactive polymers.